DEFLAZACORT CINFA 30 mg
The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.
- Active substance
- Deflazacort
- Strength
- 30 mg
- Form
- comprimido
- ATC code
- H02AB13
- Registered in
- Spain · Laboratorios Cinfa S.A.
- Prescription
- Prescription only
- Nº Registro
- 73873
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30
Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.
Listed in other countries
United States 11 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| Deflazacort | 30 mg · Tablet | Prescription only | Upsher-Smith Laboratories, LLC (+6) | 0832-0816 |
| Jaythari | 30 mg · Tablet | Prescription only | Zydus Pharmaceuticals (USA) Inc. (+1) | 70710-1751 |
| Emflaza | 30 mg · Tablet | Prescription only | PTC Therapeutics, Inc. | 52856-503 |
| Kymbee | 30 mg · Tablet | Prescription only | Upsher-Smith Laboratories, LLC | 0245-0816 |
Source: NDC Directory (US Food and Drug Administration) · 2026-09-13 · Source: US Food and Drug Administration, NDC Directory.
Netherlands 1 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| Deflazacort XGX Pharma 30 mg tabletten | 30 mg · tablet | Prescription only | XGX Pharma ApS | 124419 |
Source: Geneesmiddeleninformatiebank (College ter Beoordeling van Geneesmiddelen (CBG-MEB)) · 2026-09-30 · Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site.